×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

GLP-1s µÄÐÄÀí×÷ÓÃ

2023-09-12
|
»á¼ûÁ¿£º

GLP-1ÔÚ²î±ð×éÖ¯ÖоßÓжàÖÖ×÷ÓÃºÍÆÕ±éµÄÖÎÁÆÇ±Á¦¡£

GLP-1 shows numerous actions in different tissues, and a broad therapeutic potential.

GLP-1µÄÖ÷Òª×÷ÓÃÊǴ̼¤ÒȵºËØÉøÍ¸²¢ÒÖÖÆÒȸßѪÌÇËØÉøÍ¸£¬´Ó¶øÓÐÖúÓÚ¿ØÖƲͺóѪÌDz¨¶¯¡£

The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion,thereby contributing to limit postprandial glucose excursions.

GLP-1 ¿ÉÒÔÔöÇ¿±¥¸¹¸Ð¶øµ¼ÖÂÌåÖØ¼õÇᣬ±ðµÄ£¬GLP-1»¹ÒÖÖÆÎ¸³¦µÀÔ˶¯ºÍÉøÍ¸£¬¿ÉÒԳ䵱³¦Î¸Ëغ͡°»Ø³¦Öƶ¯¡±»úÖÆµÄÒ»²¿·Ö¡£

GLP-1 also causes weight loss by increasing satiety. In addition, GLP-1 also inhibits gastrointestinal motility and secretion,and thus acts as an enterogastrone and part of the "ileal brake" mechanism.

¸ü¶à¡°GLP-1¡±×ÊѶ

¡°GLP-1¡±ÐÂÒ©Ñз¢Ð§ÀÍÆ½Ì¨

ÒȸßѪÌÇËØÑùëÄ-1(GLP-1s) ÏÈÈÝ

GLP-1ÈÃ×¢Éä³ÔÒ©Ò²Äܼõ·Ê³ÉΪÏÖʵ

Õë¶ÔNASH·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÓÐÄÄЩ²î±ðµÄÐÂÒ©ÀàÐÍ

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿